UK markets closed

Ovid Therapeutics Inc. (OVID)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
3.0600-0.0100 (-0.33%)
At close: 04:00PM EDT
3.1500 +0.09 (+2.94%)
After hours: 07:26PM EDT
Show:
Income statement
Cash flow
Annual

Balance sheet

All numbers in thousands
Breakdown
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Assets
Current assets
Cash
Cash and cash equivalents
27,042
44,868
187,798
72,034
Other short-term investments
78,792
84,134
0
0
Total cash
105,833
129,001
187,798
72,034
Other current assets
3,764
2,379
2,682
2,668
Total current assets
109,598
131,381
190,479
74,843
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
15,664
16,652
504.965
320.957
Accumulated depreciation
-1,001
-581.381
-262.208
-185.337
Net property, plant and equipment
14,663
16,071
242.757
135.62
Equity and other investments
17,626
5,623
1,632
0
Other long-term assets
1,957
1,970
2,027
-
Total non-current assets
34,429
23,885
4,066
1,082
Total assets
144,027
155,266
194,545
75,926
Liabilities and stockholders' equity
Liabilities
Current liabilities
Accounts payable
3,703
1,953
7,127
5,446
Accrued liabilities
6,525
4,505
7,671
12,033
Deferred revenues
-
-
0
2,213
Total current liabilities
11,474
6,992
14,798
22,063
Non-current liabilities
Deferred revenues
-
-
0
10,170
Other long-term liabilities
30,000
-
-
-
Total non-current liabilities
44,756
16,002
0
10,231
Total liabilities
56,230
22,993
14,798
32,294
Stockholders' equity
Common stock
70.693
70.468
70.36
65.746
Retained earnings
-277,866
-225,527
-171,358
-294,192
Accumulated other comprehensive income
0.702
-42.187
0
0
Total stockholders' equity
87,797
132,273
179,746
43,632
Total liabilities and stockholders' equity
144,027
155,266
194,545
75,926